Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Shenzhen Stock Exchange 002693.SZ

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -5.56 M

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities is USD -5.56 M for the year ending December 31, 2023, a -185.37% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 6.51 M, a 201.85% change year over year.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -6.39 M, a -191.93% change year over year.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 6.95 M, a 131.38% change year over year.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -22.16 M, a -13.71% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shenzhen Stock Exchange: 002693.SZ

Hainan Shuangcheng Pharmaceuticals Co., Ltd.

CEO	Mr. Jianming Li
IPO Date	Aug. 8, 2012
Location	China
Headquarters	No. 16 Xingguo Road
Employees	474
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.

Key trends

Past 5 years